최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of Korean academy of nursing = 대한간호학회지, v.46 no.1, 2016년, pp.19 - 28
오복자 (삼육대학교 간호학과) , 김정혜 (울산대학교 임상전문간호학)
Purpose: The purpose of this study was to test the mediating effect of psychological distress in the relationship between chemotherapy related cognitive impairment (CRCI) and quality of life (QOL) in people with cancer. Methods: A purposive sample of 130 patients undergoing chemotherapy was recruite...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
항암화학요법은 인지기능 변화를 초래하여 암 환자에게 심리적 스트레스를 발생시키는데 심리적 스트레스의 악영향은? | 이때 심리적 디스트레스를 인지감퇴의 결과 변수이면서 삶의 질의 매개요인으로 가정하고 항암화학요법 관련 인지손상의 관련 요인을 규명하고자한다. 심리적 디스트레스는 암 환자가 정신적, 정서적으로 겪는 고통을 의미하는 것으로[11], 암 치료의 순응도를 감소시키고, 스트레스 호르몬의 분비로 면역반응을 교 란시켜 암 진행에 부정적인 영향을 주는 것으로 제시된다[12,13]. | |
인지기능은 무엇인가? | 인지기능은 정보의 선택, 습득, 통합하는 수용기능과 정보의 저장과 인출을 나타내는 기억과 학습, 정보의 정신적 조직과 재조직인 사고, 정보를 의사소통하거나 행위를 하는 표현기능을 포함하며 흔히 집중력, 기억력, 수행기능 등이 해당된다[4]. 항암화학요법 관련 인지손상은 주로 기억력과 집중력의 저하를 주 호소로 하는 증상으로 일반적으로 Chemobrain이나 Chemofog라고 한다[2]. | |
항암화학요법 관련 인지손상의 원인은? | 최근 영상 검사에서도 항암화학요법 암 환자의 전두엽과 해마 부위의 회백질이 위축되는 것으로 보고하여[5] 항암화학요법 관련 인지손상의 객관적인 정보를 제시하고 있다. 항암화학요법 관련 인지손상은 항암제의 신경독성 부작용, 누적용량 및 다른 약제나 치료제의 상호작용 영향 등 다양한 요인에 의해 신경세포가 손실되어 초래되는 것으로 제시한다[3]. 이러한 항암화학요법관련 인지손상은 항암제 투여 후 평균 1. |
Ministry of Health & Welfare, Korea Central Cancer Registry, National Cancer Center. Annual report of cancer statistics in Korea in 2012. Seoul: Ministry of Health & Welfare; 2014.
Gehring K, Roukema JA, Sitskoorn MM. Review of recent studies on interventions for cognitive deficits in patients with cancer. Expert Review of Anticancer Therapy. 2012;12(2):255-269. http://dx.doi.org/10.1586/era.11.202
Schagen SB, Muller MJ, Boogerd W, Mellenbergh GJ, van Dam FS. Change in cognitive function after chemotherapy: A prospective longitudinal study in breast cancer patients. Journal of the National Cancer Institute. 2006;98(23):1742-1745. http://dx.doi.org/10.1093/jnci/djj470
Gilroy J. Basic neurology. 3rd ed. New York, NY: McGraw-Hill Professional Publishing; 2000.
de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, Caan M, Douaud G, et al. Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging. Human Brain Mapping. 2012;33(12):2971-2983. http://dx.doi.org/10.1002/hbm.21422
Hutchinson AD, Hosking JR, Kichenadasse G, Mattiske JK, Wilson C. Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review. Cancer Treatment Reviews. 2012;38(7):926-934. http://dx.doi.org/10.1016/j.ctrv.2012.05.002
Hess LM, Insel KC. Chemotherapy-related change in cognitive function: A conceptual model. Oncology Nursing Forum. 2007;34(5):981-994. http://dx.doi.org/10.1188/07.onf.981-994
Wefel JS, Kayl AE, Meyers CA. Neuropsychological dysfunction associated with cancer and cancer therapies: A conceptual review of an emerging target. British Journal of Cancer. 2004;90(9):1691-1696. http://dx.doi.org/10.1038/sj.bjc.6601772
Jenkins V, Shilling V, Deutsch G, Bloomfield D, Morris R, Allan S, et al. A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. British Journal of Cancer. 2006;94(6):828-834. http://dx.doi.org/10.1038/sj.bjc.6603029
Pullens MJ, De Vries J, Roukema JA. Subjective cognitive dysfunction in breast cancer patients: A systematic review. Psycho-Oncology. 2010;19(11):1127-1138. http://dx.doi.org/10.1002/pon.1673
National Cancer Information Center. Recommendations for distress management in cancer patients, version 1.0 [Internet]. Seoul: Ministry for Health, Welfare and Family Affairs; 2008 [cited 2012 October 8]. Available from: http://www.cancer.go.kr/2010/04/22/Recommendations_Distress_Management_version1.pdf.
Pasquini M, Biondi M. Depression in cancer patients: A critical review. Clinical Practice and Epidemiology in Mental Health. 2007;3:2. http://dx.doi.org/10.1186/1745-0179-3-2
Lange M, Rigal O, Clarisse B, Giffard B, Sevin E, Barillet M, et al. Cognitive dysfunctions in elderly cancer patients: A new challenge for oncologists. Cancer Treatment Reviews. 2014;40(6):810-817. http://dx.doi.org/10.1016/j.ctrv.2014.03.003
Kaiser J, Bledowski C, Dietrich J. Neural correlates of chemotherapy-related cognitive impairment. Cortex. 2014;54:33-50. http://dx.doi.org/10.1016/j.cortex.2014.01.010
Kang Y. A normative study of the Korean-Mini Mental State Examination (K-MMSE) in the elderly. Korean Journal of Psychology. 2006;25(2):1-12.
Prabhu RS, Won M, Shaw EG, Hu C, Brachman DG, Buckner JC, et al. Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: Secondary analysis of RTOG 98-02. Journal of Clinical Oncology. 2014;32(6):535-541. http://dx.doi.org/10.1200/jco.2013.53.1830
Oh SM, Min KJ, Park DB. A study on the standardization of the hospital anxiety and depression scale for Koreans: A comparison of normal, depressed and anxious groups. Journal of Korean Neuropsychiatric Association. 1999;38(2):289-296.
Kim H, Yoo HJ, Kim YJ, Han OS, Lee KH, Lee JH, et al. Development and validation of Korean functional assessment cancer therapy-general (FACT-G). The Korean Journal of Clinical Psychology. 2003;22(1):215-229.
Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology. 1986;51(6):1173-1182.
Pereira J, Hanson J, Bruera E. The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer. 1997;79(4):835-842.
Meyers CA, Wefel JS. The use of the mini-mental state examination to assess cognitive functioning in cancer trials: No ifs, ands, buts, or sensitivity. Journal of Clinical Oncology. 2003;21(19):3557-3558. http://dx.doi.org/10.1200/jco.2003.07.080
Hall KE, Isaac CL, Harris P. Memory complaints in epilepsy: An accurate reflection of memory impairment or an indicator of poor adjustment? A review of the literature. Clinical Psychology Review. 2009;29(4):354-367. http://dx.doi.org/10.1016/j.cpr.2009.03.001
Hutter N, Vogel B, Alexander T, Baumeister H, Helmes A, Bengel J. Are depression and anxiety determinants or indicators of quality of life in breast cancer patients? Psychology, Health & Medicine. 2013;18(4):412-419. http://dx.doi.org/10.1080/13548506.2012.736624
Baek Y. The correlation among symptoms, anxiety, depression and quality of life in patients with colorectal cancer undergoing chemotherapy [master's thesis]. Seoul: Seoul National University; 2013.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.